Endpoints News’ Post

View organization page for Endpoints News

20,747 followers

Exclusive: Merida Biosciences launches with $121M Series A to develop treatments for autoimmune and allergic diseases, starting with Graves’ disease and food allergy.

Exclusive: Merida Biosciences gets $121M to treat autoimmune and allergy diseases at their roots

endpts.com

To view or add a comment, sign in

20,747 followers

View Profile Follow

Explore topics

Sales
Marketing
IT Services
Business Administration
HR Management
Engineering
Soft Skills
See All

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Endpoints News’ Post

Exclusive: Merida Biosciences gets $121M to treat autoimmune and allergy diseases at their roots

endpts.com

More from this author

Kennedy's anti-vaccine actions shouldn't surprise anyone

Big Pharma is losing the AI talent war

Trying to make sense of a killing

Explore topics